Immunostimulatory biodegradable implants containing the adjuvant Quil-A - Part I: Physicochemical characterisation

Journal of Drug Targeting

Volumn 16, Issue 3, 2008, Pages 213-223

  Myschik, Julia ^a   Eberhardt, Friederike ^a   Rades, Thomas ^a   Hook, Sarah ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Adjuvant; Colloidal particles; Implant; Quil A; Sustained release system

Indexed keywords

CHOLESTEROL; LIPID; OVALBUMIN; PHOSPHATIDYLCHOLINE; QUIL A; SUBUNIT VACCINE;

ARTICLE; BIODEGRADABLE IMPLANT; COLLOID; CONTROLLED STUDY; COVALENT BOND; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG STRUCTURE; FLUORESCENCE ANALYSIS; HYDROPHOBICITY; IMMUNOSTIMULATION; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SPECTROFLUOROMETRY; STRUCTURE ANALYSIS; SURFACE PROPERTY; SUSTAINED DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY;

ADJUVANTS, IMMUNOLOGIC; COLLOIDS; DELAYED-ACTION PREPARATIONS; FREEZE DRYING; LIPIDS; OVALBUMIN; SAPONINS; VACCINES, SUBUNIT;

EID: 41549138329     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860701848860     Document Type: Article

References (36)

1. Bangham, AD, Standish, MM and Watkins, JC (1965) Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol, 13, pp. 238-252.
2. Copland, MJ, Rades, T. and Davies, NM (2000) Hydration of lipid films with an aqueous solution of Quil A: A simple method for the preparation of immune-stimulating complexes. Int J Pharm, 196, pp. 135-139.
3. Copland, MJ, Rades, T., Davies, NM and Baird, MA (2005) Lipid based particulate formulations for the delivery of antigen. Immunol Cell Biol, 83, pp. 97-105.
4. Dash, AK and Cudworth II, GC (1998) Therapeutic applications of implantable drug delivery systems. J Pharmacol Toxicol Methods, 40, pp. 1-12.
5. Demana, PH, Davies, NM, Vosgerau, U. and Rades, T. (2004) Pseudo-ternary phase diagrams of aqueous mixtures of Quil A, cholesterol and phospholipid prepared by the lipid-film hydration method. Int J Pharm, 270, pp. 229-239.
6. Demana, PH, Davies, NM, Berger, B., Vosgerau, U. and Rades, T. (2004) A comparison of pseudo-ternary diagrams of aqueous mixtures of Quil A, cholesterol and phospholipid prepared by lipid-film hydration and dialysis. J Pharm Pharmacol, 56, pp. 573-580.
7. Demana, PH, Davies, NM, Berger, B. and Rades, T. (2004) Incorporation of ovalbumin into ISCOMs and related colloidal particles prepared by the lipid film hydration method. Int J Pharm, 278, pp. 263-274.
8. Demana, PH, Fehske, C., White, K., Rades, T. and Hook, S. (2004) Effect of incorporation of the adjuvant Quil A on structure and immune stimulatory capacity of liposomes. Immunol Cell Biol, 82, pp. 547-554.
9. Demana, PH, Davies, NM, Hook, S. and Rades, T. (2005) Quil A-lipid powder formulations releasing ISCOMs and related colloidal structures upon hydration. J Control Release, 103, pp. 45-59.
10. Friede, M. and Garcon, N. (2000) Vaccine comprising an iscom consisting of sterol and saponin which is free of additional detergent.
11. Gamvrellis, A., Leong, D., Hanley, JC, Xiang, SD, Mottram, P. and Plebanski, M. (2004) Vaccines that facilitate antigen entry into dendritic cells. Immunol Cell Biol, 82, pp. 506-516.
12. Gombotz, WR and Pettit, DK (1995) Biodegradable polymers for protein and peptide drug delivery. Bioconjug Chem, 6, pp. 332-351.
13. Guse, C., Koennings, S., Blunk, T., Siepmann, J. and Goepferich, A. (2006) Programmable implants - from pulsatile to controlled release. Int J Pharm, 314, pp. 161-169.
14. Guse, C., Koennings, S., Maschke, A., Hacker, M., Becker, C., Schreiner, S., Blunk, T., Spruss, T. and Goepferich, A. (2006) Biocompatibility and erosion behaviour of implants made of triglycerides and blends with cholesterol and phospholipids. Int J Pharm, 314, pp. 153-160.
15. Kensil, CR (1996) Saponins as vaccine adjuvants. Crit Rev Ther Drug Carrier Syst, 13, pp. 1-55.
16. Kersten, GFA, Spiekstra, A., Beuvery, EC and Crommelin, DJA (1991) On the structure of immune-stimulating saponin-lipid complexes (iscoms). Biochim Biophys Acta, 1062, pp. 165-171.
17. Khan, MZI, Tucker, IG and Opdebeeck, JP (1991) Cholesterol and lecithin implants for sustained release of antigen: Release and erosion in vitro, and antibody response in mice. Int J Pharm, 76, pp. 161-170.
18. Khan, MZI, Tucker, IG and Opdebeeck, JP (1993) Evaluation of cholesterol-lecithin implants for sustained delivery of antigen: Release in vivo and single-step immunisation of mice. Int J Pharm, 90, pp. 255-262.
19. Koennings, S., Beriö, A., Tessmar, J., Blunk, T. and Goepferich, A. (2007) Influence of wettability and surface activity on release behavior of hydrophilic substances from lipid matrices. J Control Release, 119, pp. 173-181.
20. Könnings, S., Copland, MJ, Davies, NM and Rades, T. (2002) A method for the incorporation of ovalbumin into immune stimulating complexes prepared by the hydration method. Int J Pharm, 241, pp. 385-389.
21. Medlicott, NJ and Tucker, IG (1999) Pulsatile release from subcutaneous implants. Adv Drug Deliv Rev, 38, pp. 139-149.
22. Morein, B. (1990) The iscom: An immunostimulating system. Immunol Lett, 25, pp. 281-284.
23. Morein, B., Sundquist, B., Hoglund, S., Dalsgaard, K. and Osterhaus, A. (1984) Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature, 308, pp. 457-460.
24. Myschik, J., Lendemans, DG, McBurney, WT, Demana, PH, Hook, S. and Rades, T. (2006) On the preparation, microscopic investigation and application of ISCOMs. Micron, 37, pp. 724-734.
25. O'Hagan, DT (2001) Recent developments in vaccine delivery systems. Curr Drug Targets Infect Disord, 1, pp. 273-286.
26. Ozel, M., Hoglund, S., Gelderblom, HR and Morein, B. (1989) Quaternary structure of the immunostimulating complex (iscom). J Ultrastruc Mol Struct Res, 102, pp. 240-248.
27. Preis, I. and Langer, RS (1979) A single-step immunization by sustained antigen release. J Immunol Methods, 28, pp. 193-197.
28. Rao, M. and Alving, CR (2000) Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells. Adv Drug Deliv Rev, 41, pp. 171-188.
29. Sjölander, A., Land, B van't and Bengtsson, K Lovgren (1997) Iscoms containing purified Quillaja saponins upregulate both Th1-like and Th2-like immune responses. Cell Immunol, 177, pp. 69-76.
30. Small, DM (1968) A classification of biologic lipids based upon their interaction in aqueous systems. J Am Oil Chem Soc, 45, pp. 108-119.
31. Storni, T., Kuendig, TM, Senti, G. and Johansen, P. (2005) Immunity in response to particulate antigen-delivery systems. Adv Drug Deliv Rev, pp. 333-355.
32. Toes, REM, Blom, RJJ, Offringa, R., Kast, WM and Melief, CJM (1996) Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumors. J Immunol, 156, pp. 3911-3918.
33. Vogelhuber, W., Magni, E., Mouro, M., Spruβ, T., Guse, C., Gazzaniga, A. and Goepferich, A. (2003) Monolithic triglyceride matrices: A controlled-release system for proteins. Pharm Dev Technol, 8, pp. 71-79.
34. Walduck, AK, Opdebeeck, JP, Benson, HE and Prankerd, R. (1998) Biodegradable implants for the delivery of veterinary vaccines: Design, manufacture and antibody response in sheep. J Control Release, 51, pp. 269-280.
35. Wikman, M., Friedman, M., Pinitkiatisakul, S., Andersson, C., Hemphill, A., Lovgren-Bengtsson, K., Lunden, A. and Stahl, S. (2005) General strategies for efficient adjuvant incorporation of recombinant subunit immunogens. Vaccine, 23, pp. 2331-2335.
36. Zinkernagel, RM, Ehl, S., Aichele, P., Oehen, S., Kuendig, T. and Hengartner, H. (1997) Antigen localisation regulates immune responses in a dose- and time-dependent fashion: A geographical view of immune reactivity. Immunol Rev, 156, pp. 199-209.